PRVA Stock Analysis: Buy, Sell, or Hold?
PRVA - Privia Health Group, Inc. Common Stock
$21.12
-0.08 (-0.38%)
▼
5d:
-4.0%
30d:
-15.42%
90d:
-6.71%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When PRVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: PRVA shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: PRVA shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$40.49
Based on 12.7% avg growth
INTRINSIC VALUE TODAY
$25.14
16.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PRVA is currently trading at $21.12, which is considered oversold relative to its 30-day fair value range of $21.74 to $26.00. The stock's valuation (Forward PE: 19.9) is in line with its historical norms (21.1). Remarkably, the market is currently pricing in an annual earnings decline of 2.0% over the next few years. This pessimistic expectation contrasts with the company's recent 250.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PRVA is showing sideways momentum. The price is currently testing key support at $21.02. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $31.67 (+49.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PRVA is showing sideways momentum. The price is currently testing key support at $21.02. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $31.67 (+49.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$21.74 -
$26.00
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
83.5%
Protect Your Profits
Holding PRVA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 49.9% below Wall St target ($31.67)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$21.74 -
$26.00
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$1.03
(4.9%)
Support & Resistance Levels
Support Level
$21.02
Resistance Level
$22.81
Current Trend
Sideways
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.86
Wall Street Target
$31.67
(+49.9%)
Revenue Growth (YoY)
21.4%
Earnings Growth (YoY)
250.0%
Profit Margin
1.2%
Valuation Discount vs History
-2.0% cheaper
PE vs Historical
19.9 vs 21.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.0%
(market-implied from PE analysis)
1-Year Target
$20.70
(-2%)
2-Year Target
$20.28
(-4%)
3-Year Target
$19.88
(-6%)
3-Yr Target (if PE normalizes)
(PE: 20→21)
$21.12
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 21.4%)
$38.20
(+81%)
Base:
(SPY PE: 19.9, Growth: 21.4%)
$37.81
(+79%)
Bear:
(PE: 16.9, Growth: 21.4%)
$32.14
(+52%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Forward PE: 23.64 | Forward EPS (Implied): $0.89
Bull Case
$25.50
(+21%)
Analyst growth 15.0%, PE expands to 24.8
Base Case
$21.12
(0%)
Market implied 0.0%, PE stable at 23.6
Bear Case
$16.16
(-24%)
Severe decline -15.0%, PE contracts to 21.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.9 to 21.1
Stabilization Target:
$22.44
(+6.2%)
PE Expansion Potential:
+6.2%
Share & Embed Analysis
Last updated: August 22, 2026 10:47 AM ET
Data refreshes hourly during market hours. Next update: 11:47 AM
Data refreshes hourly during market hours. Next update: 11:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
18
Sells
Net
INSIDERS SELLING
Recent Transactions
David Mountcastle
SELL
5566 shares
2026-04-02
David Mountcastle
SELL
6391 shares
2026-03-16
Parth Mehrotra
SELL
26509 shares
2026-03-16
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$244 | 33 SELL |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 51 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 37 SELL |
|
BTSG
BrightSpring Health Serv… |
STRONG BUY
12 analysts |
$79 | 63 BUY |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 41 HOLD |
Advanced PRVA Option Strategies
Professional options setups generated by AI based on today's PRVA price and gamma walls.
